Bayer AG
XETRA:BAYN
Bayer AG
Other Receivables
Bayer AG
Other Receivables Peer Comparison
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Other Receivables
€3.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Other Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Other Receivables
€473m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
16%
|
|
MPH Health Care AG
XETRA:93M1
|
Other Receivables
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Receivables
€148k
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Other Receivables
€539k
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Other Receivables?
Other Receivables
3.5B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Other Receivables amounts to 3.5B EUR.
What is Bayer AG's Other Receivables growth rate?
Other Receivables CAGR 10Y
6%
Over the last year, the Other Receivables growth was 1%. The average annual Other Receivables growth rates for Bayer AG have been 6% over the past three years , 5% over the past five years , and 6% over the past ten years .